65P Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: A large real life worldwide population
- Resource Type
- Abstract
- Authors
- Rimini, M.; Casadei Gardini, A.; Persano, M.; Suda, G.; Tada, T.; Shimose, S.; Kudo, M.; Cheon, J.; Finkelmeier, F.; Rimassa, L.; Presa, J.; Masi, G.; Yoo, C.; Lonardi, S.; Tovoli, F.; Piscaglia, F.; Iavarone, M.A.; Scartozzi, M.; Burgio, V.; Cascinu, S.; Cucchetti, A.
- Source
- In Immuno-Oncology and Technology December 2022 16 Supplement 1
- Subject
- Language
- ISSN
- 2590-0188